In a major development, the WHO on Wednesday said it has granted emergency use listing (EUL) to Bharat Biotech's COVID-19 vaccine Covaxin. IMAGE: Prime Minister Narendra Damodardas Modi take his......
The World Health Organisation (WHO) on Friday issued emergency use listing for anti-COVID vaccine Covovax produced by Serum Institute of India under licence from Novavax, expanding the basket of......
The World Health Organisation's technical advisory group on Tuesday sought "additional clarifications" from Bharat Biotech for its COVID-19 vaccine Covaxin to conduct a final "risk-benefit......
A technical advisory group of the World Health Organisation was on Tuesday reviewing data on Covaxin for the emergency use listing of India's indigenously-made vaccine and it could pronounce its......
India's Bharat Biotech has been submitting data on the EUL of Covaxin "regularly and very quickly" to a technical committee which hopes to have a final recommendation to the World Health......
'It will dictate the flow of funds into the index. We will maintain caution on mid/smallcaps.' Illustration: Dominic Xavier/Rediff.com Retail investors have taken to equity markets like never......
Such listings will help internationalise our currency, give us economic heft, compel best in class regulations and further develop the professional-services ecosystem., says Amit Tandon.......
The S&P BSE Sensex surged 267 points to end at 23,649 and the Nifty50 soared 83 points to close at 7,192. Benchmark indices climb for the second day amid a firm rally in the Asian equities as......